CERO

CERo Therapeutics Holdings, Inc. - Common Stock (CERO)

About CERo Therapeutics Holdings, Inc. - Common Stock (CERO)

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.

Details

Daily high

$0.86

Daily low

$0.76

Price at open

$0.82

52 Week High

$171.00

52 Week Low

$0.53

Market cap

4.1M

Dividend yield

0.00%

Volume

825,373

Avg. volume

1.0M

P/E ratio

-.01

CERo Therapeutics Holdings, Inc. - Common Stock News